November 6, 2018 8:12am

Quarterly results: Athersys (ATHX) reports Q3 today, followed by Vericel (VCEL), Ions Pharmaceuticals (IONS), Sage Therapeutics (SAGE), Spark Therapeutics (ONCE), uniQure (QURE) and Verastem (VSTM).


Today’s thematic: “street” expectation – meeting or not and how large a dose of voting humility


Once we get through quarterly LPS (loss-per-share) financial results <notice I didn’t say – <earnings season>, it will be easier for investors to possibly recognize a short or a near-term view; but my fear is that Q4 numbers aren't going to look much better than the Q3/18 numbers – look at the few who are putting-up nine (9) month numbers.

Members only. Please login.